Study Results from Fox Chase Cancer Center in the Area of Non-Small Cell Lung Cancer Reported (Phase Ii Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab In Stage Iv Nonsquamous Non-small-cell Lung ...)

Press/Media

PeriodDec 15 2023

Media coverage

1

Media coverage

  • TitleStudy Results from Fox Chase Cancer Center in the Area of Non-Small Cell Lung Cancer Reported (Phase Ii Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab In Stage Iv Nonsquamous Non-small-cell Lung ...)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date12/15/23
    PersonsHossein Borghaei